Sonia Pereira-Domingos

Lausanne, VD, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Unconventional T cells in urological cancers: catch them if you can.

Unconventional T cells in urological cancers: catch them if you can.

Journal: Nature reviews. Urology
Published: July 14, 2026

Corrigendum to "Role of myeloid-derived suppressor cells in bladder cancer and targeted therapeutic strategies" [Gene 970 (2025) 149772].

Corrigendum to "Role of myeloid-derived suppressor cells in bladder cancer and targeted therapeutic strategies" [Gene 970 (2025) 149772].

Journal: Gene
Published: March 29, 2026

Correction: Sathiyanadan et al. Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth. Int. J. Mol. Sci. 2022, 23, 2930.

Correction: Sathiyanadan et al. Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth. Int. J. Mol. Sci. 2022, 23, 2930.

Journal: International journal of molecular sciences
Published: February 26, 2026

Corrigendum to "Role of myeloid-derived suppressor cells in bladder cancer and targeted therapeutic strategies" [Gene 970 (2025) 149772].

Corrigendum to "Role of myeloid-derived suppressor cells in bladder cancer and targeted therapeutic strategies" [Gene 970 (2025) 149772].

Journal: Gene
Published: October 22, 2025

Role of myeloid-derived suppressor cells in bladder cancer and targeted therapeutic strategies.

Role of myeloid-derived suppressor cells in bladder cancer and targeted therapeutic strategies.

Journal: Gene
Published: July 15, 2025

Characterization of Ty21a immunostimulatory effects in the mouse bladder.

Characterization of Ty21a immunostimulatory effects in the mouse bladder.

Journal: Frontiers in immunology
Published: May 15, 2025

Immunomonitoring in bladder cancer: a short report on stability of leukocytes and proteins in refrigerated urine samples.

Immunomonitoring in bladder cancer: a short report on stability of leukocytes and proteins in refrigerated urine samples.

Journal: BMC urology
Published: August 29, 2024

UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract.

UROPOT: study protocol for a randomized, double-blind phase I/II trial for metabolism-based potentiation of antimicrobial prophylaxis in the urological tract.

Journal: Trials
Published: May 01, 2024

The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial).

The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial).

Journal: Trials
Published: March 20, 2024

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.

Journal: Journal for immunotherapy of cancer
Published: November 30, 2023

Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.

Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.

Journal: Frontiers in immunology
Published: November 08, 2023

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.

Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies.

Journal: International journal of molecular sciences
Published: November 28, 2022
Showing 1-12 of 28

Last Updated: 09/26/2026